Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert J A Rolden

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Social Science & Medicine (1982)|September 20, 2014
Variation in the costs of dying and the role of different health services, socio-demographic characteristics, and preceding health care expensesHerbert J A Rolden, David van Bodegom, Rudi G J Westendorp
Plos One|December 24, 2014
Changes in health care expenditure after the loss of a spouse: data on 6,487 older widows and widowers in the NetherlandsHerbert J A Rolden, David van Bodegom, Rudi G J Westendorp
Journal of Epidemiology and Community Health|October 9, 2013
Old age mortality and macroeconomic cyclesHerbert J A Rolden, David van Bodegom, Wilbert B van den Hout, et al.
BMC Medical Ethics|February 7, 2018
Combining value of information analysis and ethical argumentation in decisions on participation of vulnerable patients in clinical researchGert J van der Wilt, Janneke P C Grutters, Angela H E M Maas, et al.
BMC Cardiovascular Disorders|October 15, 2017
Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence neededHerbert J A Rolden, Angela H E M Maas, Gert Jan van der Wilt, et al.
International Journal of Technology Assessment in Health Care|June 19, 2018
THE GAP BETWEEN ECONOMIC EVALUATIONS AND CLINICAL PRACTICE: A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON DABIGATRAN FOR ATRIAL FIBRILLATIONHerbert J A Rolden, Gert Jan van der Wilt, Angela H E M Maas, et al.
Maturitas|September 12, 2015
Practice points in gynecardiology: Abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapyAngela H E M Maas, Mia von Euler, Marlies Y Bongers, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Social Science & Medicine (1982)|September 20, 2014
Variation in the costs of dying and the role of different health services, socio-demographic characteristics, and preceding health care expensesHerbert J A Rolden, David van Bodegom, Rudi G J Westendorp
Plos One|December 24, 2014
Changes in health care expenditure after the loss of a spouse: data on 6,487 older widows and widowers in the NetherlandsHerbert J A Rolden, David van Bodegom, Rudi G J Westendorp
Journal of Epidemiology and Community Health|October 9, 2013
Old age mortality and macroeconomic cyclesHerbert J A Rolden, David van Bodegom, Wilbert B van den Hout, et al.
BMC Medical Ethics|February 7, 2018
Combining value of information analysis and ethical argumentation in decisions on participation of vulnerable patients in clinical researchGert J van der Wilt, Janneke P C Grutters, Angela H E M Maas, et al.
BMC Cardiovascular Disorders|October 15, 2017
Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence neededHerbert J A Rolden, Angela H E M Maas, Gert Jan van der Wilt, et al.
International Journal of Technology Assessment in Health Care|June 19, 2018
THE GAP BETWEEN ECONOMIC EVALUATIONS AND CLINICAL PRACTICE: A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON DABIGATRAN FOR ATRIAL FIBRILLATIONHerbert J A Rolden, Gert Jan van der Wilt, Angela H E M Maas, et al.
Maturitas|September 12, 2015
Practice points in gynecardiology: Abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapyAngela H E M Maas, Mia von Euler, Marlies Y Bongers, et al.
Pageof 1